Open AccessIn Reply
Author(s) -
Brandi Giovanni,
Deserti Marzia,
Vasuri Francesco,
Farioli Andrea,
Degiovanni Alessio,
Palloni Andrea,
Frega Giorgio,
Barbera Maria A.,
Lorenzo Stefania,
Garajova Ingrid,
Di Marco Mariacristina,
Pinna Antonio D.,
Cescon Matteo,
Cucchetti Alessandro,
Ercolani Giorgio,
D'ErricoGrigioni Antonietta,
Pantaleo Maria A.,
Biasco Guido,
Tavolari Simona
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0286
Subject(s) - medicine , gemcitabine , chemotherapy , oncology , nucleoside , cancer , nucleoside analogue , genetics , biology
Brandi et al. clarify data about the localization of human equilibrative nucleoside transporter 1 in cancer patients receiving gemcitabine‐based chemotherapy. They discuss methodology, differences between antibodies, and recommendations for further study.